/PRNewswire/ Navamedic ASA (OSE: NAVA), a Nordic pharma company and provider of high-quality products to hospitals and pharmacies, has today submitted a.
Oslo, 16 February 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announces its results for the fourth quarter of 2022. In the period, Navamedic delivered another quarter with solid growth across its portfolio, resulting in a 29 per cent increase in revenues to NOK 116.0 million compared to the same quarter in 2021. For the full year of 2022, revenues amounted to NOK 382.1 million, up 37 per cent compared to 2021.
/PRNewswire/ Navamedic ASA (OSE: NAVA) will be presenting its fourth quarter 2022 results on Thursday February 16, 2023. The presentation will be held at.
Oslo, 23 November 2022 - Navamedic has signed an agreement with its partner InfoRLife SA which will expand Navamedic s portfolio of antibiotics for hospital use. Under the agreement, Navamedic. | November 23, 2022
/PRNewswire/ Oslo, 1 November 2022 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and.